Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 1
2012 1
2013 1
2015 2
2016 3
2017 1
2018 2
2019 6
2020 3
2021 1
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.
Carles J, Medina-Lopez RA, Puente J, Gómez-Ferrer Á, Nebra JC, Sáez Medina MI, Ribal MJ, Antolín AR, Álvarez-Ossorio JL, Suárez Novo JF, Agut CM, Srinivasan S, Ortiz J, Fizazi K. Carles J, et al. Among authors: gomez ferrer a. Future Oncol. 2023 Apr;19(12):819-828. doi: 10.2217/fon-2022-1131. Epub 2023 May 24. Future Oncol. 2023. PMID: 37222151 Free article. Clinical Trial.
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility.
Rossin G, Zorzi F, De Pablos-Rodríguez P, Biasatti A, Marenco J, Ongaro L, Perotti A, Tulone G, Traunero F, Piasentin A, Gomez-Ferrer A, Zucchi A, Trombetta C, Simonato A, Rubio-Briones J, Bartoletti R, Ramírez-Backhaus M, Claps F. Rossin G, et al. Among authors: gomez ferrer a. Diagnostics (Basel). 2023 Jul 31;13(15):2543. doi: 10.3390/diagnostics13152543. Diagnostics (Basel). 2023. PMID: 37568905 Free PMC article. Review.
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy.
Claps F, de Pablos-Rodríguez P, Gómez-Ferrer Á, Mascarós JM, Marenco J, Collado Serra A, Casanova Ramón-Borja J, Calatrava Fons A, Trombetta C, Rubio-Briones J, Ramírez-Backhaus M. Claps F, et al. Among authors: gomez ferrer a. Urol Oncol. 2022 Nov;40(11):489.e19-489.e26. doi: 10.1016/j.urolonc.2022.08.005. Epub 2022 Sep 26. Urol Oncol. 2022. PMID: 36175317 Free article.
Personalised indocyanine-guided lymphadenectomy for prostate cancer: a randomised clinical trial.
de Pablos-Rodríguez P, Claps F, Rebez G, Vidal Crespo N, Gómez-Ferrer Á, Mascarós JM, Collado Serra A, Caltrava Fons A, Rubio-Briones J, Casanova Ramon Borja J, Ramírez Backhaus M. de Pablos-Rodríguez P, et al. Among authors: gomez ferrer a. BJU Int. 2023 Nov;132(5):591-599. doi: 10.1111/bju.16117. Epub 2023 Jul 18. BJU Int. 2023. PMID: 37410659 Clinical Trial.
A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532).
Tombal BF, Gomez-Veiga F, Gomez-Ferrer A, López-Campos F, Ost P, Roumeguere TA, Herrera-Imbroda B, D'Hondt LA, Quivrin M, Gontero P, Villà S, Khaled H, Fournier B, Musoro J, Krzystyniak J, Pretzenbacher Y, Loriot Y. Tombal BF, et al. Among authors: gomez ferrer a. Eur Urol Oncol. 2024 Jan 24:S2588-9311(24)00034-8. doi: 10.1016/j.euo.2024.01.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38272747 Free article.
Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced Prostate Carcinoma.
Vidal Crespo N, Enguita Arnal L, Gómez-Ferrer Á, Collado Serra A, Mascarós JM, Calatrava Fons A, Casanova Ramón-Borja J, Rubio Briones J, Ramírez-Backhaus M. Vidal Crespo N, et al. Among authors: gomez ferrer a. Medicina (Kaunas). 2022 Aug 5;58(8):1057. doi: 10.3390/medicina58081057. Medicina (Kaunas). 2022. PMID: 36013525 Free PMC article.
Ex-vivo confocal fluorescence microscopy for rapid evaluation of renal core biopsy.
Mir MC, Bancalari B, Calatrava A, Casanova J, Dominguez Escrig JL, Ramirez-Backhaus M, Gomez-Ferrer A, Collado A, Wong A, Iborra I, Sanmarti O, Rubio-Briones J. Mir MC, et al. Among authors: gomez ferrer a. Minerva Urol Nefrol. 2020 Feb;72(1):109-113. doi: 10.23736/S0393-2249.19.03627-0. Epub 2019 Dec 12. Minerva Urol Nefrol. 2020. PMID: 31833726 Free article.
Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
Claps F, Ramírez-Backhaus M, Mir Maresma MC, Gómez-Ferrer Á, Mascarós JM, Marenco J, Collado Serra A, Casanova Ramón-Borja J, Calatrava Fons A, Trombetta C, Rubio-Briones J. Claps F, et al. Among authors: gomez ferrer a. Int J Urol. 2021 May;28(5):566-572. doi: 10.1111/iju.14513. Epub 2021 Mar 5. Int J Urol. 2021. PMID: 33675069
26 results